Skip to content

This is where mission meets motion.

Join us at Advanced Therapies Week

Connect with BBG Advanced Therapies in San Diego to explore integrated solutions for starting materials, testing, and biomanufacturing that can accelerate your advanced therapies from concept to clinic.

February 9-12, 2026
San Diego, CA

Advanced Therapies Week - Logo
BBG Advacned Therapies brand illustration with microscope
BBG ATW 2026 Promo Key Art
Photo of two people at the door of BBG Advanced Therapies Mobile Leukapheresis Center

Get on board at booth #705

Gain access to the world's first (and soon to be world-famous Mobile Leukaoneresis center, and see now tar our innovations can take you.

Visual depiction of Mobile Leukapheresis Bus for BBG Advanced Therapies.

Let’s connect in San Diego.

Advanced Therapies Week brings together leaders across cell and gene therapy development to explore new models for manufacturing, testing, and patient access. BBG Advanced Therapies will be on-site to explain how our access-driven solutions remove barriers across the advanced therapy lifecycle.

Whether you’re navigating early research, scaling clinical manufacturing, or rethinking decentralized collection models, we’re ready to connect.

Hear what we have to say.

THE PANEL DISCUSSION

Patient-Centric by Design: Creating Therapies with the Patient in Mind

Tuesday, February 11, 2026 | Time: 10:30-11:15 | Theatre 3

Explore how patient-centric thinking influences advanced therapy design — from donor access and collection models to manufacturing strategies and long-term scalability.

Adrienne B. Mendoza, MHA SVP BioBridge Global and COO, BBG Advanced Therapies

Adrienne B. Mendoza, MHA
SVP BioBridge Global and COO, BBG Advanced Therapies

ROUNDTABLE DISCUSSION

Decentralized Apheresis: The Next-Generation Ecosystem for Advanced Therapies

Wednesday, February 11, 2026 | 9:30 – 10:30 AM | Theatre 2

Examine emerging decentralized apheresis models and the infrastructure, regulatory considerations, and operational shifts shaping the future of advanced therapies.

Adrienne B. Mendoza, MHA SVP BioBridge Global and COO, BBG Advanced Therapies

Adrienne B. Mendoza, MHA
SVP BioBridge Global and COO, BBG Advanced Therapies

Integrated Capabilities to Support Advanced Therapies

Starting Materials Icon

Starting Materials

  • RUO and cGMP leukapheresis collections
  • Allogeneic and autologous donor access
  • Diverse, recallable donor registry
  • Full characterization and traceability
Advanced Therapies Testing Icon

Advanced Therapies Testing

  • Safety, characterization, and potency assays
  • RUO and cGMP-qualified testing
  • Custom assay development and tech transfer
  • In process release and stability testing
cGMP Biomanufacturing Icon

cGMP Biomanufacturing

  • Process development through clinical manufacturing
  • FDA, EMA, PDMA compliant cleanrooms
  • Scalable systems and electronic batch records
  • ISO certified quality management infrastructure
BBG Advanced Therapies - Schedule a time to meet at ATW 2026

Schedule time with BBG Advanced Therapies to discuss your program goals, challenges, and opportunities—before, during, or after the conference.

Schedule a meeting
BBG Global Advanced Therapies Logo

Where mission meets motion.